High blood pressure trials in Türkiye
6 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Adana, Adapazarı, Altındağ, Ankara, Antalya, Haliliye, Kahramanmaraş, Kayseri, Kocaeli, Şahinbey
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - No phaseTaking peopleAnticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism
- Where
- Bingoel, Malatya
- Age
- 18 years and over
- People
- 90
- Run by
- Hacettepe University
See details and how to joinNCT07752511 - No phaseEnrolling by invitationAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Adana, Ankara, Istanbul
- Age
- 0 Minutes to 2 weeks
- People
- 8,000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Edirne, Istanbul, Izmir, Kayseri, Malatya, Zonguldak
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Where
- Eskişehir, Istanbul, Izmir, Kocaeli, Konya, Muratpaşa, Sivas
- Age
- 18 years and over
- People
- 11,000 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07181109 · EU 2025-522960-34-00 - Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Adana, Ankara, Bursa, Eskişehir, Istanbul, Izmir, Mersin
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00